会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 문형 추출물을 유효성분으로 함유하는 화장료 조성물
    • 化妆品组合物含有成分提取物的提取物L
    • KR1020070002409A
    • 2007-01-05
    • KR1020050057934
    • 2005-06-30
    • (주)아모레퍼시픽
    • 김한성김연준이성일김수남김덕희김한곤이병곤장이섭강학희이옥섭장이섭
    • A61K8/97A61Q19/08
    • A61K8/97A61K8/0212A61Q19/08
    • A cosmetic composition comprising the extract of Equisetum arvense L. as an effective ingredient is provided to promote growth of keratinocytes, remove reactive oxygen species, increase biosynthesis of procollagen type 1 by reducing biosynthesis of MMP-1(matrix metaloproteinase-1), and inhibit aging. The cosmetic composition for promoting growth of keratinocytes, removing reactive oxygen species, increasing biosynthesis of procollagen type 1 by reducing biosynthesis of MMP-1, or inhibiting aging comprises the extract of Equisetum arvense L. and at least one extract selected from Lonicera japonica Thunberg extract, Prunus armeniaca extract, Plantago asiatica extract and Coix lacryma-jobi extract, wherein the amount of the medicinal herb extract is 0.0001 to 25 wt.% based on the total weight of the composition; the medicinal herb extracts are prepared with water; and the composition further comprises 1,3-butyleneglycol.
    • 提供了含有作为有效成分的马齿苋提取物的化妆品组合物,用于促进角质形成细胞的生长,去除活性氧,通过降低MMP-1(基质金属蛋白酶-1)的生物合成来增加1型前胶原的生物合成,抑制 老化。 用于促进角质形成细胞生长,去除活性氧的化妆品组合物,通过减少MMP-1的生物合成增加生物合成1型前胶原或抑制老化的化妆品组合物包括马齿苋提取物和至少一种选自金银花提取物(Lonicera japonica Thunberg extract)的提取物 ,山茱萸提取物,车前草提取物和枸杞提取物,其中药草提取物的量为组合物总重量的0.0001〜25重量% 药草提取物用水制备; 并且组合物还包含1,3-丁二醇。
    • 6. 发明公开
    • 항노화 효과를 나타내는 히드록삼산 유도체 및 이의제조방법
    • 羟脯氨酸衍生物显示抗体效应,其制备方法和用于外用的皮肤制剂和包含衍生物的胶原蛋白和激酶表达抑制剂
    • KR1020050022251A
    • 2005-03-07
    • KR1020040020401
    • 2004-03-25
    • (주)아모레퍼시픽
    • 노호식백흥수김수정채병근이병석김배환최규호손의동이해광김덕희장이섭이옥섭
    • C07C239/14
    • PURPOSE: Provided are a hydroxamic acid derivative which shows an antiaging effect and is improved in safety and stability to the skin stimulus and discoloration, its preparation method, and an antiaging skin preparation for external use and a collagenase and elastase expression inhibitor containing the derivative. CONSTITUTION: The hydroxamic acid derivative is represented by the formula 1, wherein R1 and R2 are H, a C1-C10 alkyl group or a C3-C6 cycloalkyl group; R3 is CONH, NHCO, CONR5 or NR5CO (wherein R5 is H or a C1-C10 alkyl group); and R4 is -(CH)n- (wherein n is 0 or 1). The method comprises the steps of reacting benzoic acid and methyl 4-aminobenzoate or 4-aminophenylacetic acid methyl ester or reacting aniline and monomethyl terephthalate, to prepare a benzamide compound; substituting the amino bond of the benzamide compound into an alkyl bond; hydrolyzing the methyl ester group to prepare an acid; and reacting the obtained acid with hydroxyl amine·HCl salt to prepare the hydroxamic acid derivative of the formula 1.
    • 目的:提供一种异羟肟酸衍生物,其表现出抗衰老作用,并且改善了皮肤刺激和变色的安全性和稳定性,其制备方法和外用抗衰老皮肤制剂以及含有该衍生物的胶原酶和弹性蛋白酶表达抑制剂。 构成:异羟肟酸衍生物由式1表示,其中R 1和R 2是H,C 1 -C 10烷基或C 3 -C 6环烷基; R3是CONH,NHCO,CONR5或NR5CO(其中R5是H或C1-C10烷基); 且R 4为 - (CH)n - (其中n为0或1)。 该方法包括使苯甲酸和4-氨基苯甲酸甲酯或4-氨基苯乙酸甲酯或苯胺与对苯二甲酸单甲酯反应制备苯甲酰胺化合物的步骤; 将苯甲酰胺化合物的氨基取代成烷基键; 水解甲基酯以制备酸; 并使所得酸与羟胺·HCl盐反应制备式1的异羟肟酸衍生物。
    • 9. 发明公开
    • 히드록삼산 유도체 및 이의 제조방법
    • 一种羟基酸衍生物及其制备方法
    • KR1020060113110A
    • 2006-11-02
    • KR1020050035986
    • 2005-04-29
    • (주)아모레퍼시픽
    • 노호식백흥수이정아박창만김덕희장이섭이옥섭
    • C07C239/18
    • C07C259/06A61K8/42A61Q19/08C07C259/10
    • Provided are a hydroxamic acid derivative which shows an antioxidizing effect and a collagen biosynthesis enhancing effect, its preparation method, and a skin preparation composition for external use containing the derivative. The hydroxamic acid derivative is represented by the formula 1, wherein R1 and R2 is a C1-C10 alkyl group; R3 is -(CH)n-; n is 0 or 1; and R4 is H or a methyl group. The method comprises the steps of reacting a 3,4-dialkoxybenzoic acid and methyl 4-aminobenzoate or methyl 4-aminophenyl acetate to prepare a benzamide compound; hydrolyzing a methyl ester group of the benzamide compound to prepare an acid; and reacting the acid with hydroxylamineÀHCl salt or N-methyl hydroxylamineÀHCl salt to prepare the hydroxamic acid derivative of the formula 1.
    • 提供显示抗氧化作用和胶原生物合成增强效果的异羟肟酸衍生物,其制备方法和含有该衍生物的外用皮肤制剂组合物。 异羟肟酸衍生物由式1表示,其中R 1和R 2是C 1 -C 10烷基; R3是 - (CH)n-; n为0或1; R4为H或甲基。 该方法包括使3,4-二烷氧基苯甲酸与4-氨基苯甲酸甲酯或4-氨基苯基乙酸甲酯反应制备苯甲酰胺化合物的步骤; 水解苯甲酰胺化合物的甲基酯以制备酸; 并使酸与羟胺-HCl盐或N-甲基羟胺-HCl盐反应以制备式1的异羟肟酸衍生物。
    • 10. 发明公开
    • 발기부전증 및 성 불감증 치료용 L-아르기닌 함유경피투여 제제
    • 用于治疗溃疡性功能障碍和易感性的L-阿金宁的超导管理的制备
    • KR1020030041433A
    • 2003-05-27
    • KR1020010072226
    • 2001-11-20
    • (주)아모레퍼시픽
    • 이영대김정주김중수이옥섭
    • A61K31/198
    • PURPOSE: A composition for transdermal administration comprising L-arginine which has excellent therapeutic effect and presents no adverse effects even when administered in excess as a main drug is provided. The composition is an external application which overcomes the defects of conventional injections or oral therapeutic agents and effective in treatment of erectile dysfunction and frigidity. CONSTITUTION: A preparation for transdermal administration contains 1 to 20% by weight of L-arginine, 1 to 30% by weight of a skin permeation enhancer, a pharmaceutically acceptable carrier and additionally 1 to 80% by weight of one or more additives selected from a solubilizing aid, a softening agent, a surfactant, a thickening agent and a pH controller. The preparation is applied to the peripheral surface of the penis and the clitoris in a single dose of about 0.1 to 2g.
    • 目的:用于透皮给药的组合物,其包含L-精氨酸,其具有优异的治疗效果,并且即使以过量作为主要药物也不会产生不良反应。 该组合物是克服常规注射或口服治疗剂的缺陷并有效治疗勃起功能障碍和寒冷的外部应用。 构成:用于透皮给药的制剂含有1至20重量%的L-精氨酸,1至30重量%的皮肤渗透促进剂,药学上可接受的载体,另外1至80重量%的一种或多种添加剂选自 增溶助剂,软化剂,​​表面活性剂,增稠剂和pH控制剂。 该制剂以约0.1至2g的单次剂量施用于阴茎和阴蒂的外周表面。